Saira Sheikh/ med.unc.edu
May 17, 2026, 10:50
CAR T-Cell Therapy and Life-Changing Progress in Autoimmune Disease – UNC Health
UNC Health shared a post on LinkedIn:
“Clinical trials are essential for developing new treatments for serious conditions.
At the UNC School of Medicine, a groundbreaking CAR T-cell therapy clinical trial is giving patients with severe autoimmune diseases like lupus a chance at a life-changing reset.
‘We’re giving patients who have suffered for so long another chance, a reset at life,’ said UNC Health rheumatologist Saira Sheikh, MD.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins
-
Jul 4, 2026, 15:41Emmanuel J. Favaloro: New Research Highlights Benchmarks for Low Molecular Weight Heparin Monitoring
-
Jul 4, 2026, 15:38Roshni Kulkarni: Maternal Mortality In Bleeding Disorders
-
Jul 4, 2026, 15:34Alejandro González Veliz: Does Elevated Lp(a) Always Mean the Same Cardiovascular Risk?
-
Jul 4, 2026, 15:20Bruno Pougault: Heparin Monitoring Remains One of the Most Challenging Areas in Laboratory Hemostasis